[1] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424. DOI: 10.3322/caac.21492 [2] 李钰, 高岩, 刘世龙, 等. 宫颈癌患者的膀胱充盈度一致性对放疗摆位误差的影响[J]. 中国辐射卫生,2020,29(3):305-308. DOI: 10.13491/j.issn.1004-714X.2020.03.027 Li Y, Gao Y, Liu SL, et al. Effect of consistency of bladder filling volume on set-up errors in radiotherapy for the patients with cervical cancer[J]. Chin J Radiol Heal, 2020, 29(3): 305-308. DOI: 10.13491/j.issn.1004-714X.2020.03.027 [3] 刘静雯, 任洪荣, 周冲, 等. 盆腔活性骨髓与宫颈癌放疗血液学毒性的关系[J]. 中国辐射卫生,2020,29(6):696-699. DOI: 10.13491/j.issn.1004-714X.2020.06.030 Liu JW, Ren HR, Zhou C, et al. Correlation between pelvic active bone marrow and hematological toxicity in radiotherapy of cervical cancer[J]. Chin J Radiol Heal, 2020, 29(6): 696-699. DOI: 10.13491/j.issn.1004-714X.2020.06.030 [4] Han K, Milosevic M, Fyles A, et al. Trends in the utilization of brachytherapy in cervical cancer in the United States[J]. Int J Radiat Oncol Biol Phys, 2013, 87(1): 111-119. DOI: 10.1016/j.ijrobp.2013.05.033 [5] Chargari C, Deutsch E, Blanchard P, et al. Brachytherapy: an overview for clinicians[J]. CA Cancer J Clin, 2019, 69(5): 386-401. DOI: 10.3322/caac.21578 [6] Prescribing, recording, and reporting brachytherapy for cancer of the cervix[J]. J ICRU, 2013, 13(1/2): NP. DOI: 10.1093/jicru/ndw027. [7] 唐笑迪, 岳海振, 赵红福. 宫颈癌高剂量率近距离治疗施源器进展[J]. 中国医疗设备,2021,36(4):153-156, 161. DOI: 10.3969/j.issn.1674-1633.2021.04.035 Tang XD, Yue HZ, Zhao HF. The progress of source applicators in high-dose-rate brachytherapy for cervical cancer[J]. China Med Devices, 2021, 36(4): 153-156, 161. DOI: 10.3969/j.issn.1674-1633.2021.04.035 [8] Nomden CN, de Leeuw AA, Moerland MA, et al. Clinical use of the Utrecht applicator for combined intracavitary/interstitial brachytherapy treatment in locally advanced cervical cancer[J]. Int J Radiat Oncol Biol Phys, 2012, 82(4): 1424-1430. DOI: 10.1016/j.ijrobp.2011.04.044 [9] Tambas M, Tavli B, Bilici N, et al. Computed tomography-guided optimization of needle insertion for combined intracavitary/interstitial brachytherapy with Utrecht applicator in locally advanced cervical cancer[J]. Pract Radiat Oncol, 2021, 11(4): 272-281. DOI: 10.1016/j.prro.2021.01.008 [10] Serban M, Kirisits C, de Leeuw A, et al. Ring versus ovoids and intracavitary versus intracavitary-interstitial applicators in cervical cancer brachytherapy: results from the EMBRACE I study[J]. Int J Radiat Oncol Biol Phys, 2020, 106(5): 1052-1062. DOI: 10.1016/j.ijrobp.2019.12.019 [11] Gursel SB, Serarslan A, Meydan AD, et al. A comparison of tandem ring and tandem ovoid treatment as a curative brachytherapy component for cervical cancer[J]. J Contemp Brachytherapy, 2020, 12(2): 111-117. DOI: 10.5114/jcb.2020.94308 [12] Jürgenliemk-Schulz IM, Lang S, Tanderup K, et al. Variation of treatment planning parameters (D90 HR-CTV, D2cc for OAR) for cervical cancer tandem ring brachytherapy in a multicentre setting: Comparison of standard planning and 3D image guided optimisation based on a joint protocol for dose-volume constraints[J]. Radiother Oncol, 2010, 94(3): 339-345. DOI: 10.1016/j.radonc.2009.10.011 [13] Kirisits C, Pötter R, Lang S, et al. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer[J]. Int J Radiat Oncol Biol Phys, 2005, 62(3): 901-911. DOI: 10.1016/j.ijrobp.2005.02.040 [14] Tanderup K, Nielsen SK, Nyvang GB, et al. From point A to the sculpted pear: MR image guidance significantly improves tumour dose and sparing of organs at risk in brachytherapy of cervical cancer[J]. Radiother Oncol, 2010, 94(2): 173-180. DOI: 10.1016/j.radonc.2010.01.001 [15] Shen S, Kim R, Duan J, et al. SU-E-T-433: pear-shaped based dose optimization for HDR intracavitary brachytherapy for cervical cancer patients with small uterus[J]. Med Phys, 2012, 39(6Part16): 3804. DOI: 10.1118/1.4735522 [16] Murakami N, Kobayashi K, Kato T, et al. The role of interstitial brachytherapy in the management of primary radiation therapy for uterine cervical cancer[J]. J Contemp Brachytherapy, 2016, 8(5): 391-398. DOI: 10.5114/jcb.2016.62938 [17] Kirisits C, Lang S, Dimopoulos J, et al. Uncertainties when using only one MRI-based treatment plan for subsequent high-dose-rate tandem and ring applications in brachytherapy of cervix cancer[J]. Radiother Oncol, 2006, 81(3): 269-275. DOI: 10.1016/j.radonc.2006.10.016 [18] Kirisits C, Lang S, Dimopoulos J, et al. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results[J]. Int J Radiat Oncol Biol Phys, 2006, 65(2): 624-630. DOI: 10.1016/j.ijrobp.2006.01.036 [19] Fokdal L, Tanderup K, Hokland SB, et al. Clinical feasibility of combined intracavitary/interstitial brachytherapy in locally advanced cervical cancer employing MRI with a tandem/ring applicator in situ and virtual preplanning of the interstitial component[J]. Radiother Oncol, 2013, 107(1): 63-68. DOI: 10.1016/j.radonc.2013.01.010 [20] Palhares DMF, Marconi DG, Azevedo TL, et al. Predicting the necessity of adding catheters to intracavitary brachytherapy for women undergoing definitive chemoradiation for locally advanced cervical cancer[J]. Brachytherapy, 2018, 17(6): 935-943. DOI: 10.1016/j.brachy.2018.07.003 [21] Dimopoulos JC, Pötter R, Lang S, et al. Dose-effect relationship for local control of cervical cancer by magnetic resonance image-guided brachytherapy[J]. Radiother Oncol, 2009, 93(2): 311-315. DOI: 10.1016/j.radonc.2009.07.001 [22] Zhang N, Tang YH, Guo X, et al. Analysis of dose-effect relationship between DVH parameters and clinical prognosis of definitive radio (chemo) therapy combined with intracavitary/interstitial brachytherapy in patients with locally advanced cervical cancer: a single-center retrospective study[J]. Brachytherapy, 2020, 19(2): 194-200. DOI: 10.1016/j.brachy.2019.09.008 [23] Tanderup K, Fokdal LU, Sturdza A, et al. Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer[J]. Radiother Oncol, 2016, 120(3): 441-446. DOI: 10.1016/j.radonc.2016.05.014 [24] Mazeron R, Castelnau-Marchand P, Escande A, et al. Tumor dose-volume response in image-guided adaptive brachytherapy for cervical cancer: a meta-regression analysis[J]. Brachytherapy, 2016, 15(5): 537-542. DOI: 10.1016/j.brachy.2016.05.009 [25] Tang XD, Mu X, Zhao ZP, et al. Dose-effect response in image-guided adaptive brachytherapy for cervical cancer: a systematic review and meta-regression analysis[J]. Brachytherapy, 2020, 19(4): 438-446. DOI: 10.1016/j.brachy.2020.02.012 [26] Li F, Lu SC, Zhao HF, et al. Three-dimensional image-guided combined intracavitary and interstitial high-dose-rate brachytherapy in cervical cancer: a systematic review[J]. Brachytherapy, 2021, 20(1): 85-94. DOI: 10.1016/j.brachy.2020.08.007 [27] Gonzalez Y, Giap F, Klages P, et al. Predicting which patients may benefit from the hybrid intracavitary+interstitial needle (IC/IS) applicator for advanced cervical cancer: a dosimetric comparison and toxicity benefit analysis[J]. Brachytherapy, 2021, 20(1): 136-145. DOI: 10.1016/j.brachy.2020.09.004 [28] Fokdal L, Sturdza A, Mazeron R, et al. Image guided adaptive brachytherapy with combined intracavitary and interstitial technique improves the therapeutic ratio in locally advanced cervical cancer: Analysis from the retroEMBRACE study[J]. Radiother Oncol, 2016, 120(3): 434-440. DOI: 10.1016/j.radonc.2016.03.020 [29] 赵红福, 程光惠, 韩东梅. 宫颈癌高剂量率三维近距离治疗计划设计[J]. 中华放射肿瘤学杂志,2018,27(5):527-532. DOI: 10.3760/cma.j.issn.1004-4221.2018.05.019 Zhao HF, Cheng GH, Han DM. Treatment plan design of three-dimensional high-dose-rate brachytherapy for cervical cancer[J]. Chin J Radiat Oncol, 2018, 27(5): 527-532. DOI: 10.3760/cma.j.issn.1004-4221.2018.05.019 [30] Tang B, Liu XY, Wang XL, et al. Dosimetric comparison of graphical optimization and inverse planning simulated annealing for brachytherapy of cervical cancer[J]. J Contemp Brachytherapy, 2019, 11(4): 379-383. DOI: 10.5114/jcb.2019.87145 [31] Zhao ZP, Zhang N, Liu Y, et al. Analysis of clinical utilization of ring applicator for combined intracavitary/interstitial image-guided brachytherapy treatment in Chinese patients with locally advanced cervical cancer[J]. J Contemp Brachytherapy, 2020, 12(3): 252-259. DOI: 10.5114/jcb.2020.96866 [32] Walter F, Maihöfer C, Schüttrumpf L, et al. Combined intracavitary and interstitial brachytherapy of cervical cancer using the novel hybrid applicator Venezia: Clinical feasibility and initial results[J]. Brachytherapy, 2018, 17(5): 775-781. DOI: 10.1016/j.brachy.2018.05.009
